Adaptive sample size modification in clinical trials: start small then ask for more?-Reference-Cited by-同舟云学术

Adaptive sample size modification in clinical trials: start small then ask for more?

Published:2015-07-14 Issue:29 Volume:34 Page:3793-3810
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Jennison Christopher¹^ORCID,Turnbull Bruce W.²

Affiliation:

1. Department of Mathematical Sciences; University of Bath; Bath U.K.

2. School of Operations Research and Information Engineering; Cornell University; Ithaca NY U.S.A.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6575/fullpdf

Reference26 articles.

1. US Food and Drug Administration Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics (draft) FDA: Silver Spring, MD 2010 http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM201790.pdf

2. Evaluation of experiments with adaptive interim analyses;Bauer;Biometrics,1994

3. Self-designing clinical trials;Fisher;Statistics in Medicine,1998

4. Modification of sample size in group sequential clinical trials;Cui;Biometrics,1999

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eliciting the Discount Parameter in a Power Prior Method on the Basis of the Type I Error Consideration;Statistics in Biopharmaceutical Research;2024-08-21

2. A systematic approach to adaptive sequential design for clinical trials: using simulations to select a design with desired operating characteristics;Journal of Biopharmaceutical Statistics;2024-05-30

3. New results on optimal conditional error functions for adaptive two-stage designs;Journal of Applied Statistics;2024-04-17

4. A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart;Statistics in Medicine;2024-04-02

5. Design and monitoring of clinical trials with an interim analysis and a negative binomial endpoint;Contemporary Clinical Trials;2024-03